Ledger.Open graph →
SEC Form D · Amendment · filed May 13, 2013

Celator Pharmaceuticals Inc

Offering
$39.3M
Sold
$39.3M
Exemption
—
Industry
Pharmaceuticals
Location
PRINCETON, NJ
Type
—

People & firms on this filing (16)

Jackson T. Scott · Princeton, NJExec · DirectorRichard S. Kollender · Princeton, NJDirectorKenneth Galbraith · Princeton, NJDirectorNicole Vitullo · Princeton, NJDirectorJoseph A. Mollica · Princeton, NJDirectorAlex Zisson · Princeton, NJDirectorLawrence Mayer · Princeton, NJExecMark Iwicki · Watertown, MAExec · DirectorEdward R. Kabala · Pittsburgh, PAExecJesse Proudman · Seattle, WADirectorJill Waltersdorph · Seattle, WADirectorStephen Balukoff · Seattle, WADirectorJulie Hillers · Seattle, WADirectorMatt Scoble · Seattle, WADirectorFred M. Powell · Princeton, NJExecScott Morenstein · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗